onycholysisL | R Documentation |
Data from the toenail onychomycosis study, a randomized double-blind comparative study comparing Terbinafine (250 mg/day) against Itraconazole (200 mg/day) over 7 weeks. This dataset is in the long format (i.e. one line per measurement).
id
: patient identifier.
group
: treatment arm to which the patient has been randomized ("itraconazole"
or "terbinafine"
).
treatment
: treatment recieved by the patient at a given timepoint ("none"
, "itraconazole"
, or "terbinafine"
).
visit
: index of time at which the measurement was taken (1
to 7
).
time
: scheduled time, in months, for each measurement (0
, 4
, 8
, 12
, 24
, 36
, 48
).
obstime
: time, in months, at which the measurement was taken (numeric between 0
and 18.5
).
response
: degree of onycholysis (separation of the nail plate from the nail-bed). Can be 0 for none or mild, 1 for moderate or severe.
data(onycholysisL)
De Backer et al. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: A double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day, Journal of the American Academy of Dermatology, (2020) 110. doi: 10.1016/s0190-9622(98)70486-4
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.